utilized a mouse model of bleomycin (BLM)-induced pulmonary fibrosis and evaluated the fibrotic potential of the IL-33-mediated ST2 signaling pathway using a therapeutic dose of ST2-Fc fusion protein. Here, IL33 is linked to pulmonary fibrosis.